Trypanosoma dionisii as an experimental model to study anti-Trypanosoma cruzi drugs: A comparative analysis with benznidazole, posaconazole and amiodarone
Open Access
- 17 October 2018
- journal article
- Published by Heighten Science Publications Corporation
- Vol. 1 (1), 014-023
- https://doi.org/10.29328/journal.ijcmbt.1001003
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Benznidazole and Posaconazole in Experimental Chagas Disease: Positive Interaction in Concomitant and Sequential TreatmentsPLoS Neglected Tropical Diseases, 2013
- Effects of amiodarone and posaconazole on the growth and ultrastructure of Trypanosoma cruziInternational Journal of Antimicrobial Agents, 2012
- Targeting Trypanosoma cruzi Sterol 14α-Demethylase (CYP51)Advances in Parasitology, 2011
- Identification and lineage genotyping of South American trypanosomes using fluorescent fragment length barcodingInfection, Genetics and Evolution, 2011
- Review onTrypanosoma cruzi: Host Cell InteractionInternational Journal of Cell Biology, 2010
- Fase aguda da doença de Chagas na Amazônia brasileira: estudo de 233 casos do Pará, Amapá e Maranhão observados entre 1988 e 2005Revista da Sociedade Brasileira de Medicina Tropical, 2008
- The Anti-Trypanosoma cruziActivity of Posaconazole in a Murine Model of Acute Chagas' Disease Is Less Dependent on Gamma Interferon than That of BenznidazoleAntimicrobial Agents and Chemotherapy, 2007
- Experimental Chemotherapy againstTrypanosoma cruziInfection: Essential Role of Endogenous Interferon‐γ in Mediating Parasitologic CureThe Journal of Infectious Diseases, 2002
- Trypanosoma (Schizotrypanum) dionisii: Influence of Mouse Peritoneal Macrophages and Calf Sera on Extracellular Growth in vitro at 37 CJournal of General Microbiology, 1978
- Comparative drug sensitivities of culture forms of Trypanosoma cruzi and Trypanosoma dionisiiNature, 1977